Search For "datar cancer genetics"
Dr Massimo Cristofanilli, MD Joins Datar Cancer Genetics as Strategic Advi
Updated : 1 year, 1 month ago IST
New York [US]/ London [UK]/ Munich [Germany]/ New Delhi [India], February 11: Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as Strategic Advisor, reinforcing its commitment to advancing early cancer detection and precisio
Read More
Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered De
Updated : 1 year, 1 month ago IST
London [UK]/ Munich [Germany]/ New Delhi [India], February 4: Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimized treatment options for cancer patients who have exhausted the standard options. It integrates a 360° tu
Read More
Datar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of
Updated : 1 year, 1 month ago IST
New Delhi [India] / London [UK] / Munich [Germany], January 28: Datar Cancer Genetics (DCG) has launched a revolutionary video-reporting service for in-vitro chemosensitivity testing, powered by AI-driven technology. This innovation provides oncologists with real-time visual evidence of chem
Read More
Datar Cancer Genetics Introduces Revolutionary Tumor-Agnostic + Informed B
Updated : 1 year, 2 months ago IST
London [UK]/ Munich [Germany]/ New Delhi [India], January 22: Datar Cancer Genetics (DCG) today announced the launch of Target-MRD, an advanced molecular residual disease (MRD) monitoring blood test for solid organ cancers. Target-MRD is a blood test based on tumor-agnostic next-generation s
Read More
US FDA Grants Breakthrough Designation for Blood Test to Help Diagnose Ina
Updated : 3 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 3 (ANI/PRNewswire): Datar Cancer Genetics announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra™-Glio', a blood test to help in the diagnosis of brain tumors. This is the thir
Read More
Blood test that can detect breast cancer, available in India now
Updated : 3 years, 9 months ago IST
New Delhi [India], June 22 (ANI): In a first-of-its-kind, a blood test can detect breast cancer at very early stages. It has been launched in India on Wednesday and has been made available by Datar Cancer Genetics, a private company which has partnered with the Apollo group of hospitals.
Read More
Datar cancer genetics announces foray into the United States with a $250m
Updated : 3 years, 10 months ago IST
Mumbai (Maharashtra) [India], May 9 (ANI/PR Newswire): Datar Cancer Genetics ("Datar"), a world-leading cancer research corporation today announced a $250 million contract with Artemis DNA, a leading USA-based diagnostic laboratory company that provides proprietary Next Generation Sequencing
Read More
US FDA grants the coveted Breakthrough Designation for early-stage prostat
Updated : 4 years, 1 month ago IST
Mumbai (Maharashtra) [India], February 15 (ANI/PR Newswire): Datar Cancer Genetics today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Designation' for its blood test to detect early-stage prostate cancer. This is the second test from the Company that has
Read More
US FDA grants breakthrough designation for early-stage breast cancer detec
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], November 20 (ANI/PRNewswire): Datar Cancer Genetics, a leading cancer research company today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Designation' for its blood test to detect early-stage Breast Cancer.
Read More
UK - National Institute for Health and Care Excellence (NICE) issues MedTe
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India] / London [UK], July 13 (ANI/PR Newswire): Datar Cancer Genetics, a world leading non-invasive cancer analytics and diagnostics company having its Research Head Quarters at Nasik, India, announced the publication of the internationally recognized MedTech Innova
Read More
Non-Invasive Liquid Biopsy to help cancer diagnosis gets CE Certification
Updated : 5 years ago IST
London [UK]/Mumbai (Maharashtra) [India], March 11 (ANI/PRNewswire): Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformite Europeenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management.
Read More
Large study shows that a simple blood test can accurately differentiate be
Updated : 5 years, 4 months ago IST
London [UK], November 9 (ANI/PRNewswire): A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy) can accurately differentiate between non-cancerous tumors versus cancerous gr
Read More